Author:
Napier Catherine,Pearce Simon H S
Publisher
Springer International Publishing
Reference97 articles.
1. Abdel-Wahab N, Shah M, Suarez-Almazor ME. Adverse events associated with immune checkpoint blockade in patients with cancer: a systematic review of case reports. PLoS One. 2016;11(7):e0160221.
2. Adams DD, Fastier FN, Howie JB, Kennedy TH, Kilpatrick JA, Stewart RD. Stimulation of the human thyroid by infusions of plasma containing LATS protector. J Clin Endocrinol Metab. 1974;39(5):826–32.
3. Arscott P, Rosen ED, Koenig RJ, Kaplan MM, Ellis T, Thompson N, et al. Immunoreactivity to Yersinia enterocolitica antigens in patients with autoimmune thyroid disease. J Clin Endocrinol Metab. 1992;75(1):295–300.
4. Arscott PL, Koenig RJ, Kaplan MM, Glick GD, Baker Jr JR. Unique autoantibody epitopes in an immunodominant region of thyroid peroxidase. J Biol Chem. 1996;271(9):4966–73.
5. Atabani SF, Thio CL, Divanovic S, Trompette A, Belkaid Y, Thomas DL, et al. Association of CTLA4 polymorphism with regulatory T cell frequency. Eur J Immunol. 2005;35(7):2157–62.